Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients

Parkinsonism: onset, progression, and mortality

Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · cited 1× · see citing works

Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties

Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,366 · see citing works

Identification of a unique TGF-β–dependent molecular and functional signature in microglia

Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · see citing works

Nomenclature of monocytes and dendritic cells in blood

Ziegler‐Heitbrock, L., Ancuța, P., Crowe, S. M., Dalod, M., Grau, V., Hart, D. N. J., Leenen, P. J. M., Liu, Y.-J., MacPherson, G. G., Randolph, G. J., et al. (2010) · Blood · doi:10.1182/blood-2010-02-258558 · Cited by 2,436 · see citing works

Genesis: cluster analysis of microarray data

Sturn, A., Quackenbush, J., & Trajanoski, Z. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.1.207 · Cited by 1,761 · see citing works

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

Serbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,658 · see citing works

Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells

Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,647 · see citing works

Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors

Cros, J. F., Cagnard, N., Woollard, K. J., Patey, N., Zhang, S., Sénéchal, B., Puel, A., Biswas, S. K., Moshous, D., Pïcard, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.012 · Cited by 1,251 · see citing works

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · see citing works

Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool

Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061 · see citing works

Cerebral Microglia Recruit Monocytes into the Brain in Response to Tumor Necrosis Factorα Signaling during Peripheral Organ Inflammation

D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675 · see citing works

Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease.

Cunningham, C., Campion, S., Lunnon, K., Murray, C. L., Woods, J. F. C., Deacon, R. M. J., Rawlins, J. N. P., & Perry, V. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.024 · Cited by 584 · see citing works

Peripheral cytokines profile in parkinson’s disease

Reale, M., Iarlori, C., Thomas, A., Gambi, D., Perfetti, B., Di Nicola, M., & Onofrj, M. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.003 · Cited by 547 · see citing works

Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS

Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., Doykan, C. E., Wu, P. M., Gali, R. R., Iyer, L. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62636 · Cited by 481 · see citing works

CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system

Mildner, A., Mack, M., Schmidt, H., Brück, W., Djukic, M., Zabel, M. D., Hille, A., Priller, J., & Prinz, M. (2009) · Brain · doi:10.1093/brain/awp144 · Cited by 445 · see citing works

MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406 · see citing works

Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease

Gao, H.-M., Zhang, F., Zhou, H., Kam, W., Wilson, B., & Hong, J.-S. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003013 · Cited by 355 · cited 1× · see citing works

Peripheral Inflammatory Biomarkers and Risk of Parkinson's Disease

Chen, H., O'Reilly, E. J., Schwarzschild, M. A., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm260 · Cited by 317 · see citing works

Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses

Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270 · see citing works

Monocytes: subsets, origins, fates and functions

Yona, S., & Jung, S. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283324f80 · Cited by 260 · see citing works

T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Appel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256 · see citing works

Exacerbation of Motor Neuron Disease by Chronic Stimulation of Innate Immunity in a Mouse Model of Amyotrophic Lateral Sclerosis

Nguyen, M. D., D'Aigle, T., Gowing, G., Julien, J.-P., & Rivest, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4786-03.2004 · Cited by 248 · see citing works

Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region

Wissemann, W. T., Hill-Burns, E. M., Zabetian, C. P., Factor, S. A., Patsopoulos, N., Hoglund, B., Holcomb, C., Donahue, R. J., Thomson, G., Erlich, H., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.009 · Cited by 189 · see citing works

Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice

Djukic, M. (2006) · Brain · doi:10.1093/brain/awl206 · Cited by 186 · see citing works

Fas (CD95) Induces Proinflammatory Cytokine Responses by Human Monocytes and Monocyte-Derived Macrophages

Park, D. R., Thomsen, A. R., Frevert, C. W., Pham, U., Skerrett, S. J., Kiener, P. A., & Liles, W. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6209 · Cited by 176 · see citing works

The role of inflammation in sporadic and familial Parkinson’s disease

Deleidi, M., & Gasser, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1352-y · Cited by 167 · see citing works

Evaluation of Interleukins, ACTH, Cortisol and Prolactin Concentrations in the Blood of Patients with Parkinson's Disease

Stypuła, G., Radek, M., Stepien, H., Żylińska, K., & Pawlikowski, M. (1996) · NeuroImmunoModulation · doi:10.1159/000097237 · Cited by 134 · see citing works

CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site.

Letellier, E., Kumar, S., Sancho-Martinez, I., Krauth, S. J., Funke-Kaiser, A., Laudenklos, S., Konecki, K., Klussmann, S., Corsini, N. S., Kleber, S., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.01.011 · Cited by 129 · see citing works

Regulation of Dopaminergic Loss by Fas in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease

Hayley, S. P., Crocker, S. J., Smith, P. D., Shree, T., Jackson-Lewis, V. R., Przedborski, S., Mount, M., Slack, R. S., Anisman, H., & Park, D. S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4564-03.2004 · Cited by 125 · see citing works

Cultured rat microglia express functional β-chemokine receptors

Boddeke, E., Meigel, I., Frentzel, S., Gourmala, N. G., Harrison, J. K., Buttini, M., Spleiss, O., & Gebicke‐Haerter, P. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00096-x · Cited by 120 · see citing works

Association between Parkinson's disease and the HLA‐DRB1 locus

Ahmed, I., Tamouza, R., Delord, M., Krishnamoorthy, R., Tzourio, C., Mulot, C., Nacfer, M., Lambert, J., Beaune, P. H., Laurent‐Puig, P., et al. (2012) · Movement Disorders · doi:10.1002/mds.25035 · Cited by 120 · see citing works

Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study

Bower, J. H., Maraganore, D. M., Peterson, B. J., Ahlskog, J. E., & Rocca, W. A. (2006) · Neurology · doi:10.1212/01.wnl.0000227906.99570.cc · Cited by 113 · see citing works

Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease

Gardai, S. J., Mao, W., Schüle, B., Babcock, M., Schoebel, S., Lorenzana, C., Alexander, J., Kim, S., Glick, H., Hilton, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071634 · Cited by 107 · see citing works

Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis

Solomon, J. N., Lewis, C. B., Ajami, B., Corbel, S. Y., Rossi, F. M. V., & Krieger, C. (2006) · Glia · doi:10.1002/glia.20331 · Cited by 105 · see citing works

Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease.

Depboylu, C., Stricker, S., Ghobril, J.-P., Oertel, W., Priller, J., & Höglinger, G. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.020 · Cited by 94 · see citing works

Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease

Funk, N., Wieghofer, P., Grimm, S., Schäfer, R., Bühring, H., Gasser, T., & Biskup, S. (2013) · Movement Disorders · doi:10.1002/mds.25300 · Cited by 81 · see citing works

Impaired cytokine production by peripheral blood mononuclear cells and monocytes/macrophages in Parkinson's disease

Hasegawa, Y., Inagaki, T., Sawada, M., & Suzumura, A. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.101003159.x · Cited by 78 · see citing works

Association of Parkinson's disease with infections and occupational exposure to possible vectors

Harris, M. A., Tsui, J. K. C., Marion, S. A., Shen, H., & Teschke, K. (2012) · Movement Disorders · doi:10.1002/mds.25077 · Cited by 68 · see citing works

Toward a functional characterization of blood monocytes

Saha, P., & Geissmann, F. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.130 · Cited by 67 · see citing works

Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease

Landau, A. M., Luk, K. C., Jones, M.-L., Siegrist‐Johnstone, R., Young, Y. K., Kouassi, É., Rymar, V. V., Dagher, A., Sadikot, A. F., & Desbarats, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050163 · Cited by 50 · see citing works

Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients

Tuettenberg, J., Seiz, M., Debatin, K., Hollburg, W., von Staden, M., Thiemann, M., Hareng, B., Fricke, H., & Kunz, C. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.03.004 · Cited by 38 · see citing works

Inhibition of intracellular tumour necrosis factor (TNF)‐α and interleukin (IL)‐6 production in human monocytes by iloprost

Czeslick, E. G., Simm, A., Grond, S., Silber, R., & Sablotzki, A. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01241.x · Cited by 37 · see citing works

DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD

Fu, K., Ren, H., Wang, Y., Fei, E., Wang, H., & Wang, G. (2011) · Oncogene · doi:10.1038/onc.2011.315 · Cited by 32 · see citing works

CD95/Fas in the Brain—Not Just a Killer

Beier, C. P., & Schulz, J. B. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.07.008 · Cited by 13 · see citing works

Inflammation and immune dysfunction in Parkinson disease

Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382 · see citing works

MCP-1: Function, regulation, and involvement in disease

Singh, S., Anshita, D., & Ravichandiran, V. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107598 · Cited by 887 · see citing works

Genome-wide pleiotropy between Parkinson disease and autoimmune diseases

Witoelar, A., Jansen, I. E., Wang, Y., Desikan, R. S., Gibbs, J. R., Blauwendraat, C., Thompson, W. K., Hernandez, D. G., Djurovic, S., Schork, A. J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0469 · Cited by 352 · see citing works

S erum immune markers and disease progression in an incident P arkinson's disease cohort ( ICICLE‐PD )

Williams‐Gray, C. H., Wijeyekoon, R., Yarnall, A. J., Lawson, R. A., Breen, D. P., Evans, J., Cummins, G. A., Duncan, G. W., Khoo, T. K., Burn, D. J., et al. (2016) · Movement Disorders · doi:10.1002/mds.26563 · Cited by 311 · see citing works

Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal

Weber, M. D., Godbout, J. P., & Sheridan, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.102 · Cited by 283 · see citing works

LRRK2 levels in immune cells are increased in Parkinson’s disease

Cook, D. A., Kannarkat, G. T., Cintron, A. F., Butkovich, L. M., Fraser, K. B., Chang, J., Grigoryan, N., Factor, S. A., West, A. B., Boss, J. M., et al. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-017-0010-8 · Cited by 279 · see citing works

Periphery and brain, innate and adaptive immunity in Parkinson’s disease

Harms, A. S., Ferreira, S. A., & Romero‐Ramos, M. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02268-5 · Cited by 279 · see citing works

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease

Heidari, A., Yazdanpanah, N., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02496-w · Cited by 275 · see citing works

Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration

Qin, H., Buckley, J. A., Li, X., Liu, Y., Fox, T. H., Meares, G. P., Yu, H., Yan, Z., Harms, A. S., Li, Y., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4658-15.2016 · Cited by 275 · see citing works

Immune aging, dysmetabolism, and inflammation in neurological diseases

Deleidi, M., Jäggle, M., & Rubino, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00172 · Cited by 260 · see citing works

Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and neurodegeneration in a model of Parkinson disease

Harms, A. S., Thome, A. D., Yan, Z., Schonhoff, A. M., Williams, G. P., Li, X., Liu, Y., Qin, H., Benveniste, E. N., & Standaert, D. G. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.010 · Cited by 236 · see citing works

Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention

Ferreira, S. A., & Romero‐Ramos, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00247 · Cited by 220 · see citing works

Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease

Hirsch, É. C., & Standaert, D. G. (2020) · Movement Disorders · doi:10.1002/mds.28075 · Cited by 191 · see citing works

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities

Araújo, B., Caridade-Silva, R., Soares-Guedes, C., Martins‐Macedo, J., Gomes, E. D., Monteiro, S., & Teixeira, F. G. (2022) · Cells · doi:10.3390/cells11182908 · Cited by 198 · see citing works

Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes

Bliederhaeuser, C., Grozdanov, V., Speidel, A., Zondler, L., Ruf, W. P., Bayer, H., Kiechle, M., Feiler, M. S., Freischmidt, A., Brenner, D., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1504-2 · Cited by 181 · see citing works

Immune system responses in Parkinson's disease: Early and dynamic

Tansey, M. G., & Romero‐Ramos, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14290 · Cited by 183 · see citing works

Early predictors of mortality in parkinsonism and Parkinson disease

Bäckström, D. C., Granåsen, G., Domellöf, M., Linder, J., Mo, S. J., Riklund, K., Zetterberg, H., Blennow, K., & Forsgren, L. (2018) · Neurology · doi:10.1212/wnl.0000000000006576 · Cited by 175 · see citing works

Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?

Robinson-Agramonte, M. D. L. A., Noris García, E., Fraga Guerra, J., Vega Hurtado, Y., Antonucci, N., Semprún-Hernández, N., Schultz, S., & Siniscalco, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063033 · Cited by 176 · see citing works

Innate immune activation in neurodegenerative diseases

Castro‐Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 167 · see citing works

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells

Garretti, F., Agalliu, D., Arlehamn, C. S. L., Sette, A., & Sulzer, D. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00303 · Cited by 162 · see citing works

Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease

Grozdanov, V., Bousset, L., Hoffmeister, M., Bliederhaeuser, C., Meier, C., Madiona, K., Pieri, L., Kiechle, M., McLean, P. J., Kassubek, J., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25557 · Cited by 161 · see citing works

Glycosphingolipids and Neuroinflammation in Parkinson’s Disease

Belarbi, K., Cuvelier, E., Bonte, M.-A., Desplanque, M., Gressier, B., Devos, D., & Chartier-Harlin, M.-C. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00408-1 · Cited by 155 · see citing works

Peripheral monocytes are functionally altered and invade the CNS in ALS patients

Zondler, L., Müller, K., Khalaji, S., Bliederhäuser, C., Ruf, W. P., Grozdanov, V., Thiemann, M., Fundel-Clemes, K., Freischmidt, A., Holzmann, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1548-y · Cited by 154 · see citing works

α-Synuclein, a chemoattractant, directs microglial migration via H 2 O 2 -dependent Lyn phosphorylation

Wang, S., Chu, C., Stewart, T., Ginghină, C., Wang, Y., Nie, H., Guo, M., Wilson, B. C., Hong, J., & Zhang, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417883112 · Cited by 156 · see citing works

The immune system in Parkinson's disease: what we know so far

Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 148 · see citing works

The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases

Zang, X., Chen, S., Zhu, J., Ma, J., & Zhai, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.872134 · Cited by 139 · see citing works

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease

Schröder, J. B., Pawlowski, M., Meyer zu Hörste, G., Gross, C. C., Wiendl, H., Meuth, S. G., Ruck, T., & Warnecke, T. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01081 · Cited by 134 · see citing works

Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments

Poirier, A.-A., Aubé, B., Côté, M., Morin, N., Di Paolo, T., & Soulet, D. (2016) · Parkinson s Disease · doi:10.1155/2016/6762528 · Cited by 130 · see citing works

Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment?

Gładysz, D., Krzywdzińska, A., & Hozyasz, K. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0822-x · Cited by 130 · see citing works

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease

Atashrazm, F., Hammond, D. A., Perera, G., Dobson‐Stone, C., Mueller, N., Pickford, R., Kim, W. S., Kwok, J. B., Lewis, S. J. G., Halliday, G. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33921-x · Cited by 126 · see citing works

Differential contribution of microglia and monocytes in neurodegenerative diseases

Baufeld, C., O'Loughlin, E. K., Calcagno, N., Madore, C., & Butovsky, O. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 123 · see citing works

Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells

Smith, A. M., Depp, C., Ryan, B. J., Johnston, G. I., Alegre‐Abarrategui, J., Evetts, S. G., Rolinski, M., Baig, F., Ruffmann, C., Simon, A. K., et al. (2018) · Movement Disorders · doi:10.1002/mds.104 · Cited by 114 · see citing works

Innate and adaptive immune responses in Parkinson's disease

Schonhoff, A. M., Williams, G. P., Wallen, Z. D., Standaert, D. G., & Harms, A. S. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.006 · Cited by 115 · see citing works

Parkinson’s disease: experimental models and reality

Jiang, P., & Dickson, D. W. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1788-5 · Cited by 113 · see citing works

Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs: other regulatory populations are also involved

Álvarez‐Luquín, D. D., Arce-Sillas, A., Leyva-Hernández, J., Sevilla-Reyes, E. E., Boll, M., Montes-Moratilla, E. U., Vivas-Almazán, V., Pérez-Correa, C. A., Rodríguez-Ortiz, U., Espinosa-Cárdenas, R., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1606-1 · Cited by 109 · see citing works

Parkinson’s progression prediction using machine learning and serum cytokines

Rastegar, D. A., Ho, N., Halliday, G. M., & Dzamko, N. L. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0086-4 · Cited by 107 · see citing works

Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease

Wijeyekoon, R., Kronenberg‐Versteeg, D., Scott, K. M., Hayat, S., Kuan, W., Evans, J., Breen, D. P., Cummins, G. A., Jones, J., Clatworthy, M. R., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.018 · Cited by 102 · see citing works

Abnormalities of age-related T cell senescence in Parkinson’s disease

Williams‐Gray, C. H., Wijeyekoon, R., Scott, K. M., Hayat, S., Barker, R., & Jones, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1206-5 · Cited by 98 · see citing works

Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease

Williams, G. P., Schonhoff, A. M., Jurkuvenaite, A., Thome, A. D., Standaert, D. G., & Harms, A. S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1286-2 · Cited by 90 · see citing works

Alterations in Blood Monocyte Functions in Parkinson's Disease

Nissen, S. K., Shrivastava, K., Schulte, C., Otzen, D. E., Goldeck, D., Berg, D., Møller, H. J., Maetzler, W., & Romero‐Ramos, M. (2019) · Movement Disorders · doi:10.1002/mds.27815 · Cited by 89 · see citing works

Functional alterations of myeloid cells during the course of Alzheimer’s disease

Thome, A. D., Faridar, A., Beers, D. R., Thonhoff, J. R., Zhao, W., Wen, S., Pascual, B., Masdeu, J. C., & Appel, S. H. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0293-1 · Cited by 83 · see citing works

Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder

Farmen, K., Nissen, S. K., Stokholm, M. G., Iranzo, Á., Østergaard, K., Serradell, M., Otto, M., Svendsen, K. B., Garrido, A., Vilas, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020858118 · Cited by 80 · see citing works

The Endotoxin Hypothesis of Parkinson's Disease

Brown, G. C., Camacho, M., & Williams‐Gray, C. H. (2023) · Movement Disorders · doi:10.1002/mds.29432 · Cited by 81 · see citing works

Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease

Thome, A. D., Atassi, F., Wang, J., Faridar, A., Zhao, W., Thonhoff, J. R., Beers, D. R., Lai, E. C., & Appel, S. H. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00188-5 · Cited by 79 · see citing works

LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s

Wallings, R. L., Herrick, M. K., & Tansey, M. G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00443 · Cited by 77 · see citing works

Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease

Kuštrimović, N. Z., Marino, F., & Cosentino, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181009161048 · Cited by 74 · see citing works

Modeling neuro-immune interactions during Zika virus infection

Mesci, P., Macia, Á., LaRock, C. N., Tejwani, L., Fernandes, I. R., Suarez, N. A., Zanotto, P. M. D. A., Beltrão-Braga, P. C. B., Nizet, V., & Muotri, A. R. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx382 · Cited by 71 · see citing works

Role of Peripheral Immune Cells-Mediated Inflammation on the Process of Neurodegenerative Diseases

Yang, Q., Wang, G., & Zhang, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582825 · Cited by 71 · see citing works

Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes

Parillaud, V. R., Lornet, G., Monnet, Y., Privat, A., Haddad, A. T., Brochard, V., Bekaert, A., de Chanville, C. B., Hirsch, E., Combadière, C., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0830-9 · Cited by 68 · see citing works

Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease

Schiess, M. C., Suescun, J., Doursout, M., Adams, C., Green, C., Saltarrelli, J. G., Savitz, S. I., & Ellmore, T. M. (2021) · Movement Disorders · doi:10.1002/mds.28582 · Cited by 69 · see citing works

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?

Armentero, M., Cerri, S., & Blandini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00232 · Cited by 70 · see citing works

Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)

Alster, P., Madetko‐Alster, N., Koziorowski, D., & Friedman, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00893 · Cited by 66 · see citing works

Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson’s disease: Potential clinical and therapeutic implications

Angelopoulou, E., Paudel, Y. N., Shaikh, M. F., & Piperi, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104930 · Cited by 64 · see citing works

Brain and Systemic Inflammation in De Novo Parkinson's Disease

Yacoubian, T. A., Fang, Y.-H. D., Gerstenecker, A. T., Amara, A. W., Stover, N. P., Ruffrage, L., Collette, C., Kennedy, R., Zhang, Y., Hong, H., et al. (2023) · Movement Disorders · doi:10.1002/mds.29363 · Cited by 63 · see citing works

T-cell dysregulation is associated with disease severity in Parkinson’s Disease

Bhatia, D., Grozdanov, V., Ruf, W. P., Kassubek, J., Ludolph, A. C., Weishaupt, J. H., & Danzer, K. M. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02296-8 · Cited by 62 · see citing works

Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease

Muñoz‐Delgado, L., Macías‐García, D., Periñán, M. T., Jesús, S., Adarmes-Gómez, A. D., Bonilla‐Toribio, M., Buiza‐Rueda, D., Jiménez‐Jaraba, M. V., Zamora, B. B., Belloso, R. D., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00457-5 · Cited by 62 · see citing works

Oligomeric α-Synuclein Is Increased in Basal Tears of Parkinson’S Patients

Hamm‐Alvarez, S. F., Okamoto, C. T., Janga, S. R., Feigenbaum, D., Edman, M. C., Freire, D., Shah, M., Ghanshani, R., Mack, W. J., & Lew, M. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0167 · Cited by 62 · see citing works

A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson’s disease in older people: an EXosomes in PArkiNson Disease (EXPAND) ancillary study

Calvani, R., Picca, A., Landi, G., Marini, F., Biancolillo, A., Coelho‐Júnior, H. J., Gervasoni, J., Persichilli, S., Primiano, A., Arcidiacono, A., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00192-2 · Cited by 61 · see citing works

The systemic immune response in Parkinson’s disease: focus on the peripheral immune component

Lauritsen, J., & Romero‐Ramos, M. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.005 · Cited by 64 · see citing works

Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease

Nissen, S. K., Ferreira, S. A., Nielsen, M. C., Schulte, C., Shrivastava, K., Hennig, D., Etzerodt, A., Graversen, J. H., Berg, D., Maetzler, W., et al. (2020) · Movement Disorders · doi:10.1002/mds.28424 · Cited by 60 · see citing works

Immune mechanisms and shared immune targets in neurodegenerative diseases

Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 63 · see citing works

Alpha synuclein in hematopoiesis and immunity

Pei, Y., & Maitta, R. W. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02590 · Cited by 60 · see citing works

Leucine Rich Repeat Kinase 2 and Innate Immunity

Rastegar, D. A., & Dzamko, N. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00193 · Cited by 62 · see citing works

The Mechanisms of Sevoflurane-Induced Neuroinflammation

Huang, X., Ying, J., Yang, D., Fang, P., Wang, X., Zhou, B., Zhang, L., Yang, F., Yu, W., Liu, X., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.717745 · Cited by 61 · see citing works

Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognition

Nissen, S. K., Farmen, K., Carstensen, M., Schulte, C., Goldeck, D., Brockmann, K., & Romero‐Ramos, M. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.01.005 · Cited by 61 · see citing works

The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets

Ekwudo, M. N., Gubert, C., & Hannan, A. J. (2024) · FEBS Journal · doi:10.1111/febs.17102 · Cited by 60 · see citing works

Genetic manipulation of microglia during brain development and disease

Wieghofer, P., & Prinz, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.019 · Cited by 58 · see citing works

Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells

Navarro, E., Udine, E., Lopes, K. D. P., Parks, M., Riboldi, G., Schilder, B. M., Humphrey, J., Snijders, G. J. L., Vialle, R. A., Zhuang, M., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00110-x · Cited by 48 · see citing works

Impaired activation of ALS monocytes by exosomes

Zondler, L., Feiler, M. S., Freischmidt, A., Ruf, W. P., Ludolph, A. C., Danzer, K. M., & Weishaupt, J. H. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.89 · Cited by 56 · see citing works

A monocyte gene expression signature in the early clinical course of Parkinson’s disease

Schlachetzki, J. C. M., Prots, I., Tao, J., Chun, H. B., Saijo, K., Gosselin, D., Winner, B., Glass, C. K., & Winkler, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-28986-7 · Cited by 57 · see citing works

Cocaine-induced release of CXCL10 from pericytes regulates monocyte transmigration into the CNS

Niu, F., Liao, K., Hu, G., Sil, S., Callen, S. E., Guo, M., Yang, L., & Buch, S. J. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201712011 · Cited by 56 · see citing works

Specific immune status in Parkinson’s disease at different ages of onset

Tian, J., Dai, S., Jiang, S., Yang, W., Yan, Y., Lin, Z., Dong, J., Liu, Y., Zheng, R., Chen, Y., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-021-00271-x · Cited by 55 · see citing works

α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease

Liu, Z., Chan, R., Cai, Z., Liu, X., Wu, Y., Yu, Z., Feng, T., Yang, Y., & Zhang, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02413-1 · Cited by 55 · see citing works

Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System

Ivan, D. C., Walthert, S., Berve, K., Steudler, J., & Locatelli, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609921 · Cited by 53 · see citing works

Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases

Balestri, W., Sharma, R., da Silva, V. A., Bobotis, B. C., Curle, A. J., Kothakota, V., Kalantarnia, F., Hangad, M. V., Hoorfar, M., Jones, J., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03024-8 · Cited by 53 · see citing works

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis

Wijeyekoon, R. S., Kronenberg-Versteeg, D., Scott, K. M., Hayat, S., Jones, J. L., Clatworthy, M. R., Floto, R. A., Barker, R. A., & Williams-Gray, C. H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00870 · Cited by 50 · see citing works

Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration

Dolatshahi, M., Sabahi, M., & Aarabi, M. H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02236-2 · Cited by 49 · see citing works

Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages

Rastegar, D. A., Hughes, L. P., Perera, G., Keshiya, S., Zhong, S., Gao, J., Halliday, G. M., Schüle, B., & Dzamko, N. L. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00297-9 · Cited by 49 · see citing works

Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.

Deng, Q.-Y., Zhou, X., Chen, J., Pan, M.-Q., Gao, H., Zhou, J., Wang, D.-M., Chen, Q., Zhang, X.-M., Wang, Q., et al. (2017) · Brain Research · doi:10.1016/j.brainres.2016.11.007 · Cited by 48 · see citing works

α-Synuclein induces Th17 differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson's disease

Li, J., Zhao, J., Chen, L., Gao, H., Zhang, J., Wang, D., Zou, Y., Qin, Q., Qu, Y., Li, J., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.023 · Cited by 48 · see citing works

Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases

Bossù, P., Spalletta, G., Caltagirone, C., & Ciaramella, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00632 · Cited by 48 · see citing works

Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease

Magnusen, A. F., Hatton, S. L., Rani, R., & Pandey, M. K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.636139 · Cited by 47 · see citing works

Inflammasomes: An Emerging Mechanism Translating Environmental Toxicant Exposure Into Neuroinflammation in Parkinson’s Disease

Anderson, F. L., Coffey, M., Berwin, B. L., & Havrda, M. C. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy219 · Cited by 47 · see citing works

Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease

Carlisle, S. M., Qin, H., Hendrickson, R. C., Muwanguzi, J. E., Lefkowitz, E. J., Kennedy, R., Yan, Z., Yacoubian, T. A., Benveniste, E. N., West, A. B., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00180-z · Cited by 46 · see citing works

The complex role of inflammation and gliotransmitters in Parkinson's disease

Gopinath, A., Mackie, P. M., Phan, L. T., Tansey, M. G., & Khoshbouei, H. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105940 · Cited by 45 · see citing works

Cerebrospinal fluid biomarker for Parkinson's disease: An overview

Maass, F., Schulz, I., Lingor, P., Mollenhauer, B., & Bähr, M. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.12.005 · Cited by 44 · see citing works

Microglia and Other Myeloid Cells in Central Nervous System Health and Disease

Gopinath, A., Collins, A., Khoshbouei, H., & Streit, W. J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265058 · Cited by 41 · see citing works

COVID-19 associated nervous system manifestations

Khatoon, F., Prasad, K., & Kumar, V. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.07.005 · Cited by 43 · see citing works

Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol

Greenland, J. C., Cutting, E., Kadyan, S., Bond, S. J., Chhabra, A., & Williams‐Gray, C. H. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040527 · Cited by 43 · see citing works

Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice

Gao, L., Brenner, D., Llorens-Bobadilla, E., Saiz-Castro, G., Frank, T., Wieghofer, P., Hill, O., Thiemann, M., Karray, S., Prinz, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20132423 · Cited by 42 · see citing works

Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms

Schilder, B. M., Navarro, E., & Raj, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105580 · Cited by 42 · see citing works

The cervical lymph node contributes to peripheral inflammation related to Parkinson’s disease

Liu, Z., Huang, Y., Wang, X.-J., Li, J.-Y., Zhang, C., Yang, Y., & Zhang, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02770-5 · Cited by 33 · see citing works

Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson’s disease

Kozina, E. A., Byrne, M. D., & Smeyne, R. J. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00289-9 · Cited by 39 · see citing works

Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson’s disease

Su, Y., Shi, C., Wang, T., Liu, C., Yang, J., Zhang, S., Fan, L., Zheng, H., Li, X., Luo, H., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11258-w · Cited by 38 · see citing works

Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson’s disease

Green, H., Zhang, X., Tiklová, K., Volakakis, N., Brodin, L., Berg, L., Greengard, P., Perlmann, T., & Svenningsson, P. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621218114 · Cited by 39 · see citing works

Systemic Inflammation in Lewy Body Diseases

King, E., & Thomas, A. J. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000211 · Cited by 38 · see citing works

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease

Du, T., Wang, L., Liu, W., Zhu, G., Chen, Y., & Zhang, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.645996 · Cited by 41 · see citing works

Anti-Inflammatory Effects of Dimethyl Fumarate in Microglia via an Autophagy Dependent Pathway

Lee, Y., Gupta, D. P., Park, S. H., Yang, H., & Song, G. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.612981 · Cited by 37 · see citing works

T cells, α-synuclein and Parkinson disease

Garretti, F., Monahan, C., Sette, A., Agalliu, D., & Sulzer, D. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00023-0 · Cited by 39 · see citing works

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

Bliederhaeuser, C., Zondler, L., Grozdanov, V., Ruf, W. P., Brenner, D., Melrose, H. L., Bauer, P. O., Ludolph, A. C., Gillardon, F., Kassubek, J., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0396-2 · Cited by 37 · see citing works

DOI 10.1007/s00401-014-1345-4 ORIGINAL PAPER Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients

Grozdanov, V., Bliederhaeuser, C., Ruf, W. P., Roth, V., Fundel-Clemens, K., Zondler, L., Brenner, D., Martín-Villalba, A., Hengerer, B., Kassubek, J., et al. (2016)

Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson’s disease

Su, Y., Shi, C., Wang, T., Liu, C., Yang, J., Zhang, S., Fan, L., Zheng, H., Li, X., Luo, H., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11258-w · Cited by 38 · see citing works

Alterations in Blood Monocyte Functions in Parkinson's Disease

Nissen, S. K., Shrivastava, K., Schulte, C., Otzen, D. E., Goldeck, D., Berg, D., Møller, H. J., Maetzler, W., & Romero‐Ramos, M. (2019) · Movement Disorders · doi:10.1002/mds.27815 · Cited by 89 · see citing works

Toll‐like receptor 10 controls TLR2‐induced cytokine production in monocytes from patients with Parkinson's disease

Sobrinho, H. M. D. R., Gomes, R. S., da Silva, D. J., Quixabeira, V. B. L., Joosten, L. A. B., Cardoso, C. R. D. B., & Ribeiro‐Dias, F. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24916 · Cited by 11 · see citing works

Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson’s disease

Thome, A. D., Wang, J., Atassi, F., Thonhoff, J. R., Faridar, A., Zhao, W., Beers, D. R., Lai, E. C., & Appel, S. H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1571074 · Cited by 17 · see citing works